entertainment -WSS

entertainment

author：focus 2025-10-02 22:27:40 - browse：276

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Teladoc has a new CEO, but challenges remain the same

focus

WSS

California wildfire smoke linked to 52,000 early deaths, study says

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Burning questions about Delta and the next phase of the Covid pandemic

Coercive sterilizations revealed by STAT prompt outrage

Men with early prostate cancer can safely opt out of treatment

hotspot

entertainment

focus

The cancer drug shortage isn’t new — and neither are the solutions

Inside the culture of fear in the White House science office of Eric Lander

Heart attack and stroke risk calculators need revising

Statins reduce cardiovascular risk in people living with HIV

Medicare proposal to cover medical devices draws a mixed reaction

Thousands protest mob assault of women who were paraded naked in remote Indian border state

How to save PrEP access — and even expand it

FAMU bans football players from facility after release of rap video shot in team's locker room

New air purifier tech could be key to improving indoor air quality

Doctors have an ethical obligation to be advocates

explore

Statins reduce cardiovascular risk in people living with HIV

5 takeaways from STAT's examination of Zynex Medical

What Henrietta Lacks's story taught me about my role as a doctor

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

'Essentially witchcraft:' A former naturopath takes on the field

ALS patient reclaims some autonomy thanks to wearable 'robot'

focus

explore

focus

Wikipedia